WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 834 shares, a decrease of 61.0% from the February 26th total of 2,136 shares. Based on an average trading volume of 3,129 shares, the short-interest ratio is currently 0.3 days.
WuXi AppTec Trading Down 0.7%
OTCMKTS WUXAY opened at $14.25 on Friday. The business’s fifty day simple moving average is $14.65 and its 200-day simple moving average is $14.07. WuXi AppTec has a 52 week low of $5.73 and a 52 week high of $16.35.
Analyst Ratings Changes
Separately, The Goldman Sachs Group upgraded WuXi AppTec to a “buy” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Featured Stories
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
